Sheffield
United Kingdom
22
2019-03-21
10
2018-07-24
These are the the leading inventors for applications assigned to ASTERION LIMITED:
ASTERION LIMITED based in Sheffield, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
FUSION POLYPEPTIDE COMPRISING THE EXTRACELLULAR BINDING DOMAIN OF GROWTH HORMONE RECEPTOR
#2 | 2017-01-19 ✅ Patent 10,030,062 granted on 2018-07-24Growth hormone fusion proteins with growth hormone receptor agonist activity
#3 | 2014-11-13 ✅ Patent 9,493,536 granted on 2016-11-15Growth hormone receptor antagonists
#4 | 2013-01-24 ✅ Patent 8,470,559 granted on 2013-06-25Growth hormone fusion proteins
#5 | 2011-11-10ERYTHROPOIETIN
#6 | 2011-07-28GRANULOCYTE COLONY STIMULATING FACTOR
#7 | 2011-06-23INSULIN-LIKE GROWTH FACTOR FUSION PROTEINS
#8 | 2011-04-21LEPTIN FUSION PROTEINS
#9 | 2010-12-16INTERFERON LAMBDA FUSION POLYPEPTIDES
#10 | 2010-08-05 ✅ Patent 8,273,552 granted on 2012-09-25Modified growth hormone polypeptides
#11 | 2010-08-05 ✅ Patent 8,293,709 granted on 2012-10-23Growth hormone fusion proteins
#12 | 2010-02-11POLYPEPTIDE ANTAGONIST
#13 | 2009-10-29GROWTH FACTOR
#14 | 2009-09-24Modified Fusion Polypeptides
#15 | 2009-09-03Linkers
#16 | 2009-02-26 ✅ Patent 8,173,782 granted on 2012-05-08Fusion protein comprising growth hormone and growth hormone receptor
#17 | 2008-11-04 ✅ Patent 7,446,183 granted on 2008-11-04Fusion protein comprising growth hormone and growth hormone receptor
#18 | 2007-03-08Polypeptide variants
#19 | 2006-09-14 ✅ Patent 7,625,998 granted on 2009-12-01Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositol
#20 | 2005-09-29Polypeptide variants
#21 | 2005-06-09 ✅ Patent 7,524,649 granted on 2009-04-28Modified growth hormone fusion polypeptides
#22 | 2005-03-17 ✅ Patent 7,485,713 granted on 2009-02-03Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol
82511 ⎘